The Forensic Science Geek of the Week
Please visit the www.TheTruthAboutForensicScience.com FaceBook fan page.
The week 62 “www.TheTruthAboutForensicScience.com Forensic Science Geek of the Week” honors goes to: Robert Lantz, Ph.D.
According to his website (Rocky Mountain Instrumentation Laboratories):
We provide contract chromatographic and mass spectrometric analysis (HPLC/MS) of pharmaceuticals (both traditional drugs and biotechnology products, such as proteins and peptides and oligonucleotides), veterinary and human endocrinology, and forensic toxicology, including fentanyl, T HC, tryptamines, and other forensic testing and testimony. We now offer assays for certain antibiotics (cephalosporins and aminoglycosides) and the insecticide Fipronil. We develop stability-indicating assays, including degradant identification, for the pharmaceutical industry. We also provide therapeutic drug monitoring for several less-common drugs, such as Taxol, Doxorubicin, Tacrolimus, rapamycin ( Sirolimus.) and Everolimus. Everything that we do is centered about and united by chemical testing. We offer HPLC/MS/MS, HPLC/PDA, GC/MS/MS, FT/IR, Dissolution, and Stability Testing. We are FDA registered and inspected, follow cGLP protocols, and are CLIA certified. We also are certified by the Colorado Department of Health to perform clinical and forensic toxicology testing. We also have a number of LCMSMS analyses for antibiotics, such as cephapirin, amoxicillin, and vancomycin. We provide both clinical and pre-clinical method development and performance. Robert K. Lantz, Ph.D. and Patricia L. Sulik, Ph.D. are the directors of RML.
Congratulations to our Forensic Science Geek of the Week winner
OFFICIAL QUESTION:
- Forensic Science Geek of the Week Challenge
1. What specific technique is depicted in this photo?
2. Why is it performed?
3. Explain it.
4. What are its limitations?
Our Geek of the Week answered:
It is a ThermoFinnigan GCMS system, with autosampler. The GC is used to separate the volatile components in the pill extract. If the compound is not volatile or gives an uninteresting MS, derivatization can be used to make the substance more volatile or have a more definitive MS.
GC has much better resolution potential than does LC (HPLC), so the retention time for the analyte compound is more informative.
The limitations of the system include the lack of MSMS capability, and the common problem with all GC experiments, that the analyte must be volatile. I do not own this particular instrument, so I cannot speak to other features of this model. If it is an ion trap MS, some have an MSMS option.
Some analytes, such as methampehtamine provide non-characteristic mass spectra and may not separate from likely interferences, such as phentermine. Derivatization will, in this case, improve both the usefulness of the MS and the retention time. That is, the MS of meth and phentermine are identical. However, if the molecules are derivatized, the MS are quite different, as are the retention times.
[BLOGGER’S NOTE: Great answer. Thanks for participating.]
The Hall of Fame for the www.TheTruthAboutForensicScience.com Forensic Science Geek of the Week:
Week 1: Chuck Ramsay, Esquire
Week 2: Rick McIndoe, PhD
Week 3: Christine Funk, Esquire
Week 4: Stephen Daniels
Week 5: Stephen Daniels
Week 6: Richard Middlebrook, Esquire
Week 7: Christine Funk, Esquire
Week 8: Ron Moore, B.S., J.D.
Week 9: Ron Moore, B.S., J.D.
Week 10: Kelly Case, Esquire and Michael Dye, Esquire
Week 11: Brian Manchester, Esquire
Week 12: Ron Moore, B.S., J.D.
Week 13: Ron Moore, B.S., J.D.
Week 14: Josh D, Lee, Esquire
Week 15: Joshua Dale, Esquire and Steven W. Hernandez, Esquire
Week 16: Christine Funk, Esquire
Week 17: Joshua Dale, Esquire
Week 18: Glen Neeley, Esquire
Week 19: Amanda Bynum, Esquire
Week 20: Josh D. Lee, Esquire
Week 21: Glen Neeley, Esquire
Week 22: Stephen Daniels
Week 23: Ron Moore, B.S., J.D.
Week 24: Bobby Spinks
Week 25: Jon Woolsey, Esquire
Week 26: Mehul B. Anjaria
Week 27: Richard Middlebrook, Esquire
Week 28:Ron Moore, Esquire
Week 29: Ron Moore, Esquire
Week 30: C. Jeffrey Sifers, Esquire
Week 31: Ron Moore, Esquire
Week 32: Mehul B. Anjaria
Week 33: Andy Johnston
Week 34: Ralph R. Ristenbatt, III
Week 35: Brian Manchester, Esquire
Week 36: Ron Moore, Esquire
Week 37: Jeffrey Benson
Week 38: Pam King, Esquire
Week 39: Josh D. Lee, Esquire
Week 40: Robert Lantz, Ph.D.
WEEK 41: UNCLAIMED, IT COULD BE YOU!
Week 42: Steven W. Hernandez, Esquire
Week 43:Ron Moore, Esquire
Week 44: Mehul B. Anjaria
Week 45: Mehul B. Anjaria
Week 46:Ron Moore, Esquire
Week 47:Ron Moore, Esquire
Week 48: Leslie M. Sammis, Esquire
Week 49: Ron Moore, Esquire
Week 50: Jeffery Benson
Week 51: Mehul B. Anjaria
Week 52: Ron Moore, Esquire
Week 53: Eric Ganci, Esquire
Week 54: Charles Sifers, Esquire and Tim Huey, Esquire
Week 55: Joshua Andor, Esquire
Week 56: Brian Manchester, Esquire
Week 57: Ron Moore, Esquire
Week 58: Eric Ganci, Esquire
Week 59: Ron Moore, Esquire
Week 60: Brian Manchester, Esquire
Week 61: William Herringer, Esquire
Week 62: Robert Lantz, Ph.D.
Week 63: Ginger Moss
Week 64: Richard L. Holcomb, Esquire
Week 65: John L. Buckley, Esquire
Week 66: Jeff Sifers, Esquire
Week 67: Josh D. Lee, Esquire
Week 68: Dr. Barbara Vonderhaar, PhD.
Week 69: Christine Funk, Esquire
Week 70: Mehul B. Anjaria
Week 71: Ron Moore, Esquire
Week 72: Mehul B. Anjaria
Week 73: Josh D. Lee, Esquire
Week 74: Kim Keheley Frye, Esquire
Week 75: Mehul B. Anjaria and Peter Carini, Esquire
Week 76: Kim Keheley Frye, Esquire
Week 77: Mehul B. Anjaria
Week 78: Steven W. Hernandez, Esquire
Week 79: Kevin Feeney, Esquire
Week 8o: Justin Harris, Esquire
Week 81: UNCLAIMED. IT COULD BE YOU!
Week 82: Jay Tiftickjian, Esquire
Week 83: Robert Lantz, Ph.D.
Week 84: Steven W. Hernandez, Esquire
Week 85: Pat Arata, Esquire
Week 86: George Schiro
Week 87: Jay Tiftickjian, Esquire
Week 88: Rocky Babson, Esquire
Week 89: UNCLAIMED. IT COULD BE YOU.
Week 90: Joseph Rome, Esquire
Week 91: Chuck Ramsay, Esquire
Week 92: Laura Magnuson
Week 93: John L. Buckley, Esquire
Week 94: Unclaimed. It could be you!
Week 95: George Schiro
Week 96: Robert Lantz, Ph.D.